Next, we developed a cell line with a permanent knockdown of ptgs2 (B16/PTGS2Δ) by using CRISPR/Cas9 technology, in order to study the effect of ptgs2 deletion in melanoma development and progression. Here, PTGS2 is linked to melanoma.